ASPI (ASP Isotopes) YoY EBITDA Growth: -52.10% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASPI ASP Isotopes Inc ASPI
30 GF Score
Price $4.73
! 8 Warning Signs
View Full Analysis

What is ASP Isotopes YoY EBITDA Growth?

ASP Isotopes ASPI +0.63% 30 YoY EBITDA Growth is -52.10% as of Mar. 2026. GuruFocus rates ASPI with a GF Score™ of 30/100. The stock has 8 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ASP Isotopes's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -52.10%.

ASP Isotopes's EBITDA per Share for the three months ended in Mar. 2026 was $-0.18.

ASP Isotopes YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for ASP Isotopes's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASP Isotopes YoY EBITDA Growth Chart

ASP Isotopes Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
0.00 0.00 -163.78 -16.19 -233.69

ASP Isotopes Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.23 -479.55 -21.74 -347.37 -52.10
ASPI
30GF Score
ASP Isotopes Inc ASPI
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASP Isotopes YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ASP Isotopes's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-1.892--0.567)/ | -0.567 |
=-233.69 %

ASP Isotopes's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(-0.181--0.119)/ | -0.119 |
=-52.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -52.10% mean?
ASP Isotopes (ASPI) has a YoY EBITDA Growth of -52.10% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ASP Isotopes and its competitors.
Is ASP Isotopes' YoY EBITDA Growth too high?
ASP Isotopes' current YoY EBITDA Growth is -52.10%. Overall, ASP Isotopes has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does ASP Isotopes' YoY EBITDA Growth compare to LXU and WLKP?
ASP Isotopes' YoY EBITDA Growth of -52.10% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Chemicals company?
A good YoY EBITDA Growth depends on the Chemicals industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for ASP Isotopes and its competitors. ASP Isotopes's current YoY EBITDA Growth is -52.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASP Isotopes stock overvalued right now?
ASP Isotopes (ASPI) has a current YoY EBITDA Growth of -52.10%. The current YoY EBITDA Growth is -52.10%. ASP Isotopes' overall GF Score™ is 30/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For ASP Isotopes (ASPI), the current YoY EBITDA Growth is -52.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASP Isotopes Business Description

Other Exchanges ISO:South AfricaW62:Germany
Address 2200 Ross Avenue, Suite 4575 East, Dallas, TX, USA, 75201
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
30GF Score

Get the complete analysis for ASPI

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.73
Price